This protocol is judged by an institutional evaluation board, an independent group that assessments any scientific trials involving humans. If a analyze requires a Plan I drug, when the board approves the protocol as ethical, the researchers must apply for an investigational new drug (IND) selection within the FDA.When underneath the influence of